Pharma News

Keep updating your pharma knowledge
1 Dec 2014

Top 10 blockbuster pharmaceuticals by sales worldwide in 2013

Drugs which generates annual sales of at least $1 billion for the company is called blockbuster drugs. Followings are the top 10 blockbuster drugs in terms of sales in 2013.

Humira 10.7 BillionAbbVie
Enbrel  8.776 Billion-Amgen, Pfizer, Takeda
Remicade  8.38 Billion –  Janssen, Merck, Mitsubishi Tanabe Pharma
Advair/Seretide – GlaxoSmithKline / 7.86 Billion
Lantus 7.59 Billion Sanofi
Rituxan/MabThera $7.50 billion – Roche, Biogen Idec
Avastin  $6.751 billion Roche
Herceptin $6.56 billion Roche 
Crestor – AstraZeneca $6.044 billion  
Abilify  $5.501 billion Bristol-Myers Squibb, Otsuka   

 

Important fact:

1. Humira – The anti-inflammatory drug Humira was not only the best-selling biologic; it was the the best-selling drug worldwide, period.

2. In the top 10 list, there are 7 biologics – Humira – Adalimumab, Remicade – Infliximab, Rituxan – Rituximab, Enbrel-Etanercept, Lantus – Insulin glargine [rDNA origin] injection, Avastin – Bevacizumab, Herceptin – Trastuzumab.

Source: Company annual report.

Leave a Reply


The reCAPTCHA verification period has expired. Please reload the page.

Upskill Your Pharma Knowledge

Explore Next Gen Learning

Case Studies & Caselets | Simulation Based Learning | E-Lectures | Online Self Competency Assessments

Thank You for Subscription!